期刊文献+

卵巢特异性启动子调控白细胞介素-24基因对卵巢癌细胞系SKOV3的杀伤作用 被引量:1

Treatment of ovarian cancer cell line SKOV3 with IL-24 gene under the control of ovarian-specific promoter-1
原文传递
导出
摘要 目的 探讨卵巢特异启动子OSP-1调控下的白细胞介素(IL)-24基因对卵巢癌细胞系SKOV3的体外杀伤作用.方法 应用基因重组技术构建OSP-1调控下的IL-24基因真核表达载体pcDNA3.0-OSP-1-IL-24,应用脂质体将该基因载体转染入人卵巢癌细胞SKOV3、人肝癌细胞HepG2及人成纤维细胞BJ.应用RT-PCR及ELISA方法检测IL-24基因在各组细胞内和培养上清中的表达情况,应用流式细胞术及M TT法检测IL-24基因对各组细胞杀伤作用.结果 pcDNA3.0-OSP-1-IL-24转染的3组细胞中,只有SKOV3细胞可检测到IL-24基因的表达,且只对SKOV3细胞有明显杀伤作用,而对其他两组细胞无杀伤作用.但OSP-1启动子系统杀伤SKOV3细胞的效能明显低于CMV启动子.MTT检测结果分析显示,转染pcDNA3.0-OSP-1-IL-24的SKOV3细胞培养上清对SKOV3细胞的生长有明显抑制作用.结论 卵巢特异性启动子调控下的IL-24基因能够特异杀伤卵巢癌细胞,是一种新的卵巢癌靶向治疗方法. Objective To explore the in vitro antitumor effect of interleukin-24 (IL-24) gene regulated by ovarian-specific promoter-1 (OSP-1) on human ovarian cancer cell line SKOV3.Methods An expression vector (pcDNA3.0-OSP-1-IL-24) containing IL-24 gene under ovarian-specific promoter-1 was constructed by molecular biological methods and then transfected into human ovarian cancer cell SKOV3,human hepatoma cell HepG2 and human fibroblast BJ by cationic liposome.Reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) were used to detect the IL-24 gene in cells and supernatants.The antitumor effects of IL-24 gene were investigated by direct cell count,flow cytometry and methyl thiazolyl tetrazolium (MTT) assay.Results After transfections with pcDNA3.0-OSP-1-IL-24,the expression of IL-24 gene was detected only in SKOV3 cells.And only the growth of SKOV3 cells was inhibited significantly while those of HepG2 and BJ cells were not affected.The culture supernatant of SKOV3 cells transfected with pcDNA3.0-OSP-1-IL-24 could significantly inhibit the growth of SKOV3 cells.But the antitumor efficiency in SKOV3 cells of OSP-1 system was significantly lower than that of CMV promoter system.Conclusion With a high specificity,IL-24 gene therapy under the control of ovarian-specific promoter-1 is a novel target for the treatment of ovarian cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第33期2622-2627,共6页 National Medical Journal of China
基金 吉林省科技发展计划重点科技攻关项目(20140204023YY) 吉林省产业技术研究与开发项目(2013C026-4)
关键词 卵巢特异性启动子 白细胞介素-24 基因治疗 卵巢癌 Ovarian-specific promoter-1 Interleukin-24 Gene therapy Ovarian cancer
  • 相关文献

参考文献4

二级参考文献56

共引文献11

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部